Metraipolis › archive › dc_4078bcfa6bec

Clinical outcomes of tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma: insights from a single-center study — Europe PMC PMID:40847083

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40847083
DOI
10.1007/s12185-[numero omesso]-z
License (as archived)
solo-consultazione
Archived
2026-11-10T10:09:08.244Z
SHA-256 of the archived text
2e8b877a023a1f5a427bc50ad0f8c0f3dd76d4a6c3dc9e9fb4523c18cfb9de4e
Stable URL of this page
https://metraipolis.com/documento/dc_4078bcfa6bec

How to cite

Clinical outcomes of tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma: insights from a single-center study — Europe PMC PMID:40847083 — Europe PMC (en), https://europepmc.org/article/MED/40847083 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4078bcfa6bec (Metraipolis archive dc_4078bcfa6bec, sha256 2e8b877a023a1f5a427bc50ad0f8c0f3dd76d4a6c3dc9e9fb4523c18cfb9de4e)
BibTeX
@misc{dc4078bcfa6bec,
  title = {Clinical outcomes of tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma: insights from a single-center study — Europe PMC PMID:40847083},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40847083},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4078bcfa6bec; sha256 2e8b877a023a1f5a427bc50ad0f8c0f3dd76d4a6c3dc9e9fb4523c18cfb9de4e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40847083. Agents can read the archived copy with the MCP tool read_document.